Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Sohu.com (NASDAQ:SOHU) Reports Q3 Results Driven by Online Game Upswing

Sohu.com Limited (NASDAQ:SOHU) reported a meaningful turnaround in the third quarter of 2025, fueled by accelerated momentum in its online game portfolio. Total revenues reached USD 180 million, an increase of 19% year-over-year and 43% quarter-over-quarter. Online game revenues accounted for USD 162 million …

Team Kalkine | 17 November 2025

Beneficient (Nasdaq:BENF) Q2 2026: Lower Costs, Portfolio Adjustments and Capital Actions

Beneficient (Nasdaq:BENF) released its fiscal second quarter 2026 results, highlighting meaningful progress in cost discipline,capital structurealignment, and regulatory compliance. Interim CEO James Silk emphasized that the quarter marked a pivotal phase for the company, with a renewed focus on execution,liquidityimprovement, and operational efficiency.

Team Kalkine | 17 November 2025

Prairie Operating Co. (NASDAQ:PROP) Quarterly Update Shows Growth Across the DJ Basin

Prairie Operating Co. (NASDAQ:PROP) delivered another impactful quarter as it continued scaling its presence in the Denver-Julesburg Basin following itsacquisitionof Bayswater Exploration & Productionassets. The company posted record production levels of 23,029 Boe/d in Q3 2025, with volumes comprising approximately 52% oil and 72% …

Team Kalkine | 17 November 2025

Predictive Oncology (POAI:NASDAQ) New Digital Asset Treasury Reshapes Business Direction

Predictive Oncology launched a new digital asset treasury strategy centered on the ATH token.

Team Kalkine | 17 November 2025

Waldencast (NASDAQ:WALD) Sells Obagi Japan Trademark and Secures New Credit Facility

Waldencast plc(NASDAQ:WALD)has taken a significant financial step with the sale of its rights to the “Obagi” trademark in Japan to Rohto Pharmaceutical Co., Ltd. for USD 82.5 million. Rohto has held the license for the “Obagi” mark in Japan since 2002 and over the …

Team Kalkine | 17 November 2025

Eledon Pharmaceuticals (NASDAQ:ELDN) BESTOW Trial Results Shape Path to Phase 3 in Q3

Eledon Pharmaceuticals (NASDAQ:ELDN) released its third quarter 2025 update, highlighting significant clinical, regulatory, and financial developments. Central to the announcement were the encouraging results from the Phase 2 BESTOW trial, which evaluated tegoprubart as a potential alternative to traditional immunosuppressive therapies in kidney transplantation. …

Team Kalkine | 17 November 2025

Boral Capital Reissues "Buy" Rating on Trevi Therapeutics (NASDAQ:TRVI)

Trevi Therapeutics (NASDAQ:TRVI) has received a series of updates from research firms in recent days. D. Boral Capital reaffirmed its "buy" rating on the stock with a target price of $19.00, suggesting a potential upside from the stock's most recent close. This aligns with …

Team Kalkine | 16 November 2025

REV (NYSE:REVG) Expands Horton Emergency Vehicles with USD 2.6M Manufacturing Investment

REV Group(NYSE:REVG),the parent company of Horton Emergency Vehicles, has announced a significant USD 2.6Minvestmentto expand the ambulance manufacturer’s operations in Grove City, Ohio. The company has acquired a 20,000-square-foot building adjacent to Horton’s existing facility, aiming to enhance production efficiency, streamline delivery processes, and …

Team Kalkine | 16 November 2025

Viasat (NASDAQ:VSAT): Launch of ViaSat-3 F2 Expands Multi-Orbit Connectivity Vision

Viasat, Inc. (NASDAQ:VSAT) has confirmed the successful launch and first signal acquisition of its ViaSat-3 Flight 2 satellite, representing a major step in the company’s multi-orbit expansion plans. The satellite lifted off on Nov. 14, 2025, at 10:04 p.m. EST aboard a United Launch …

Team Kalkine | 16 November 2025

Rocket Lab (Nasdaq:RKLB): ESCAPADE Twin Spacecraft Begin Mars Journey for NASA and UC Berkeley

Rocket Lab Corporation (Nasdaq:RKLB)has confirmed that its two Explorer-class spacecraft for NASA and the University of California Berkeley’s Space Sciences Laboratory have successfully launched, beginning their multi-year journey to Mars. The ESCAPADE mission—Escape and Plasma Acceleration and Dynamics Explorers—lifted off aboard Blue Origin’s New …

Team Kalkine | 16 November 2025